# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Laryngeal cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 47 results.
Nomograms to Precisely Predict Conditional Risk of Survival for Patients With Laryngeal Cancer
Status: Recruiting
Last Changed: Nov 27, 2018
First Received: Nov 20, 2018
Disease(s): Laryngeal Cancer
Intervention(s): Radical Operation
Locations: Genglong Liu, Guangzhou, State..., China
Nomograms to Precisely Predict Conditional Risk of Recurrence for Patients With Laryngeal Cancer
Status: Recruiting
Last Changed: Jul 23, 2018
First Received: Jul 23, 2018
Disease(s): Recurrent Laryngeal Cancer
Intervention(s): Recurrence laryngeal cancer
Locations: Genglong Liu, Guangzhou, Guangdong, China
Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer Patients
Status: Recruiting
Last Changed: Nov 22, 2019
First Received: Nov 22, 2019
Disease(s): Laryngeal Cancer, Nursing
Intervention(s): Routine nursing care, Perioperative Enhanced Recovery After Surgery (ERAS) Based Nursing Model
Locations: Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer
Status: Recruiting
Last Changed: Feb 26, 2019
First Received: Jun 08, 2015
Disease(s): Squamous Cell Carcinoma of the Larynx
Intervention(s): radiation
Locations: University of Texas Southwestern Medical Center, Dallas, Texas, United States
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
Status: Recruiting
Last Changed: May 16, 2019
First Received: Apr 14, 2017
Disease(s): Malignant Neoplasms of Respiratory and Intrathoracic Organs, Squamous Cell Carcinoma of the Larynx
Intervention(s): Stereotactic Hypofractionated Radioablation, Questionnaires
Locations: University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Jul 24, 2019
Disease(s): Laryngeal Squamous Cell Carcinoma, Stage II Laryngeal Cancer AJCC v8, Stage III Laryngeal Cancer AJCC v8
Intervention(s): Carboplatin, Cisplatin, Docetaxel, Pembrolizumab
Locations: M D Anderson Cancer Center, Houston, Texas, United States
A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal Cancer
Status: Recruiting
Last Changed: Jan 09, 2018
First Received: Jan 05, 2018
Disease(s): Laryngeal Neoplasms, Malignant Neoplasm of Supraglottis Primary, Neck Dislocation
Intervention(s): Unilateral Neck Dissection, Bilateral Neck Dissection
Locations: Cancer Hospital, Chinese Academy of Medical Science, Beijing, Beijing, China
Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer
Status: Recruiting
Last Changed: Apr 08, 2019
First Received: Apr 28, 2017
Disease(s): Hypopharyngeal Carcinoma, Laryngeal Carcinoma
Intervention(s): Pharyngo laryngeal MRI
Locations: Service ORL et chirurgie cervico-faciale, Hôpital de la Croix rousse, Lyon, France
Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.
Status: Recruiting
Last Changed: May 13, 2019
First Received: Sep 25, 2017
Disease(s): Larynx Cancer
Intervention(s): Interviews, Treatmentchoice Decisional Tool, Questionnaires, Interviews with stakeholders
Locations: MAASTRO Clinic, Maastricht, Netherlands
Olaparib and Radiotherapy in Head and Neck Cancer
Status: Recruiting
Last Changed: Jun 27, 2019
First Received: Sep 01, 2014
Disease(s): Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell, Head and Neck Neoplasms
Intervention(s): radiotherapy, Olaparib
Locations: The Netherlands Cancer Institute, Amsterdam, Netherlands